Matthew Morrill and Christopher Pericak
Our research team reports live from the 2012 meeting of the Radiological Society of North America held in Chicago, Ill. We offer a preview of the major themes expected to emerge from the studies presented at this year's meeting.
The theme at the 2012 RSNA meeting is "Patients First," which seems straightforward at first glance. However, this year's presentations will reveal many surprises about how clinicians are achieving this principle.
Of the 13,162 abstracts submitted for consideration, RSNA coordinators accepted 5,246 for presentations. These studies coalesce into several sub-themes, all of which focus on helping providers appropriately and affordably use imaging to improve patient care.
RSNA 2012: A preview of major themes
In September 2012, the National Institutes of Health ended a large federal study (n=5,145) involving teams of researchers at 16 different U.S. centers intended to evaluate the extent to which diet and exercise reduce the chance of fatal heart diseases in diabetics. During the study, half of the patients underwent an intensive diet and exercise regimen while the other half only received general health information.
Using these groups, investigators involved with the Look AHEAD (Action for Health in Diabetes) research sought to extend findings from a Finnish study in which a rigorous diet and exercise program prevented or delayed the onset of type 2 diabetes in overweight and obese individuals with impaired glucose tolerance.
Instead, the Look AHEAD study was halted 11 years into the proposed 13 year trial. Authors concluded that the diet and exercise program resulting in weight loss did not decrease the chance of cardiovascular events such as heart attacks and strokes in people with chronic type 2 diabetes.
Diet and weight loss may not prevent fatal heart diseases in diabetics
Chris Pericak and Dave Gaffin
A local news outlet in West Sussex, UK, recently released an article titled "New Factory to Produce Proton Therapy Systems", conjuring images of factory workers piecing widgets together in a systematic fashion that would make Henry Ford proud.
A closer read, however, reveals that the article is referring to UK-based Tesla Engineering, which makes superconducting magnets that play a role in bringing new small-scale proton therapy models to market. The construction of this new factory reflects a proton therapy supply chain that is readying itself for market proliferation of this technology.
Proton therapy made on an assembly line?